Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Metabolic Syndrome |
📓
Administration with Quinoa Protein Reduces the Blood Pressure in Spontaneously Hypertensive Rats and Modifies the Fecal Microbiota. Nutrients (Nutrients ) Vol: 13 Issue 7 Pages: Pub: 2021 Jul 17 Epub: 2021 Jul 17 Authors Guo H , Hao Y , Fan X , Richel A , Everaert N , Yang X , Ren G , Html Article Publication |
| Metabolic Syndrome |
📓
Characterization of the gut microbiota in diabetes mellitus II patients with adequate and inadequate metabolic control. BMC research notes (BMC Res Notes ) Vol: 14 Issue 1 Pages: 238 Pub: 2021 Jun 24 Epub: 2021 Jun 24 Authors Hamasaki-Matos AJ , Cóndor-Marín KM , Aquino-Ortega R , Carrillo-Ng H , Ugarte-Gil C , Silva-Caso W , Aguilar-Luis MA , Del Valle-Mendoza J , Html Article Publication |
| Metabolic Syndrome |
📓
Fecal Metaproteomics Reveals Reduced Gut Inflammation and Changed Microbial Metabolism Following Lifestyle-Induced Weight Loss. Biomolecules (Biomolecules ) Vol: 11 Issue 5 Pages: Pub: 2021 May 12 Epub: 2021 May 12 Authors Biemann R , Buß E , Benndorf D , Lehmann T , Schallert K , Püttker S , Reichl U , Isermann B , Schneider JG , Saake G , Heyer R , Html Article Publication |
| Metabolic Syndrome |
📓
Gut Microbiome of Indonesian Adults Associated with Obesity and Type 2 Diabetes: A Cross-Sectional Study in an Asian City, Yogyakarta. Microorganisms (Microorganisms ) Vol: 9 Issue 5 Pages: Pub: 2021 Apr 22 Epub: 2021 Apr 22 Authors Therdtatha P , Song Y , Tanaka M , Mariyatun M , Almunifah M , Manurung NEP , Indriarsih S , Lu Y , Nagata K , Fukami K , Ikeda T , Lee YK , Rahayu ES , Nakayama J , Html Article Publication |
| Metabolic Syndrome |
📓
Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats. BMC microbiology (BMC Microbiol ) Vol: 21 Issue 1 Pages: 141 Pub: 2021 May 5 Epub: 2021 May 5 Authors Li L , Zhong SJ , Hu SY , Cheng B , Qiu H , Hu ZX , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
